4.5 Article Proceedings Paper

Leptin resistance and hippocampal behavioral deficits

期刊

PHYSIOLOGY & BEHAVIOR
卷 176, 期 -, 页码 207-213

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.physbeh.2017.03.002

关键词

-

资金

  1. Department of Veterans Affairs [I01 BX001804, I21 BX002085]
  2. Center for Targeted Therapeutics - COBRE [P20 GM109091-03]
  3. National Science Foundation [IOS-1656626]
  4. South Carolina Translational Research Institute (NIH/NCATS) [UL1TR00062]
  5. South Carolina Translational Research Institute (Pilot Project Program)

向作者/读者索取更多资源

The adipocyte-derived hormone leptin is an important regulator of body weight and metabolism through activation of brain leptin receptors expressed in regions such as the hypothalamus. Beyond these well described and characterized activities of leptin in the hypothalamus, it is becoming increasingly clear that the central activities of leptin extend to the hippocampus. Indeed, leptin receptors are expressed in the hippocampus where these receptors are proposed to mediate various aspects of hippocampal synaptic plasticity that ultimately impact cognitive function. This concept is supported by studies demonstrating that leptin promotes hippocampal-dependent learning and memory, as well as studies indicating that leptin resistance is associated with deficits in hippocampal-dependent behaviors and in the induction of depressive-like behaviors. The effects of leptin on cognitive/behavioral plasticity in the hippocampus may be regulated by direct activation of leptin receptors expressed in the hippocampus; additionally, leptin-mediated activation of synaptic networks that project to the hippocampus may also impact hippocampal-mediated behaviors. In view of these previous observations, the goal of this review will be to discuss the mechanisms through which leptin facilitates cognition and behavior, as well as to dissect the loci at which leptin resistance leads to impairments in hippocampal synaptic plasticity, including the development of cognitive deficits and increased risk of depressive illness in metabolic disorders such as obesity and type 2 diabetes mellitus (T2DM). Published by Elsevier

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据